Anticancer effects of combinational treatment with BRAFV600E siRNA and PI3K pathway inhibitors in melanoma cell lines harboring BRAFV600E

Hongyan He(Peking University), Lihe Zhang(Peking University)
Oncology Letters
May 2, 2018
Cited by 10


Related Papers